MicroRNA and mRNA expression associated with ectopic germinal centers in thymus of myasthenia gravis.

Abstract

BACKGROUND:

A characteristic pathology of early onset myasthenia gravis is thymic hyperplasia with ectopic germinal centers (GC). However, the mechanisms that trigger and maintain thymic hyperplasia are poorly characterized. Dysregulation of small, non-coding microRNAs (miRNAs) and their target genes has been identified in the pathology of several autoimmune diseases. We assessed the miRNA and mRNA profiles of the MG thymus and have investigated their role in GC formation and maintenance.

METHODS:

MG thymus samples were assessed by histology and grouped based upon the appearance of GC; GC positive and GC negative. A systems biology approach was used to study the differences between the groups. Our study included miRNA and mRNA profiling, quantitative real-time PCR validation, miRNA target identification, pathway analysis, miRNA-mRNA reciprocal expression pairing and interaction.

RESULTS:

Thirty-eight mature miRNAs and forty-six annotated mRNA transcripts were differentially expressed between the two groups (>1.5 fold change, ANOVA p<0.05). The miRNAs were found to be involved in immune response pathways and identified in other autoimmune diseases. The cellular and molecular functions of the mRNAs showed involvement in cell death and cell survival, cellular proliferation, cytokine signaling and extra-cellular matrix reorganization. Eleven miRNA and mRNA pairs were reciprocally regulated. The Regulator of G protein Signalling 13 (RGS13), known to be involved in GC regulation, was identified in specimens with GC and was paired with downregulation of miR-452-5p and miR-139-5p. MiRNA target sites were validated by dual luciferase assay. Transfection of miRNA mimics led to down regulation of RGS13 expression in Raji cells.

CONCLUSION:

Our study indicates a distinct miRNA and mRNA expression pattern in ectopic GC in MG thymus. These miRNAs and mRNAs are involved in regulatory pathways common to inflammation and immune response, cell cycle regulation and anti-apoptotic pathways suggesting their involvement in support of GC formation in the thymus. We demonstrate for the first time that miR-139-5p and miR-452-5p negatively regulate RGS13 expression.

• Authors: Manjistha Sengupta, Bi-Dar Wang, Norman H Lee, Alexander Marx, Linda L Kusner, Henry J Kaminski
• Journal: PloS one (PLoS One) Vol. 13 Issue 10 Pg. e0205464 ( 2018) ISSN: 1932-6203 [Electronic] United States
• PMID: 30308012 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)

Chemical References

• MIRN139 microRNA, human
• MIRN452 microRNA, human
• MicroRNAs
• RGS Proteins
• RGS13 protein, human
• RNA, Messenger

Topics

• Adult
• Cell Line
• Gene Expression Profiling (methods)
• Gene Expression Regulation
• Gene Regulatory Networks
• Germinal Center (chemistry)
• Humans
• MicroRNAs (genetics)
• Middle Aged
• Myasthenia Gravis (genetics)
• RGS Proteins (genetics)
• RNA, Messenger (genetics)
• Signal Transduction
• Systems Biology (methods)
• Thymus Gland
• Young Adult